Biotechnology News: Breaking Biotechnology News, Comments and Articles.

RNL BIO and Human Biostar to Offer Direct-to-Consumer Adult Stem Cell Banking in the United States

SEOUL, South Korea, May 20, 2013 /PRNewswire/ -- RNL BIO Co. Ltd., a stem cell biotechnology company dedicated to the commercialization of autologous cell therapy products for a variety of degenerative, ischemic and other indications, announces the availability of adult stem cell banking in the United States beginning on June 20, 2013.  RNL BIO previously offered these services through a...

Vince Wilfork Visits EMD Millipore’s Jaffrey, NH Manufacturing Facility

Thanks Employees for Supporting the Vince Wilfork Foundation EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany was pleased to host New England Patriots captain and defensive lineman, Vince Wilfork, his wife Bianca, and teammates Justin Francis and Marcus Forston at its Jaffrey facility on May 15, 2013.

Onyx Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 10:30 AM

ONYX Pharmaceuticals, Inc. (ONXX) May 21, 2013 10:30 am ET Executives Matthew K. Fust - Chief Financial Officer, Principal Accounting Officer and Executive Vice President Analysts Andrew Peters - UBS Investment Bank, Research Division Presentation Andrew Peters - UBS Investment Bank, Research Division Hello and good morning. My name is Andrew Peters, and I'm on the biotech equity r...

Cell Therapeutics, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 02:30 PM

Cell Therapeutics, Inc. (CTIC) May 21, 2013 2:30 pm ET Executives James A. Bianco - Principal Founder, Chief Executive Officer, President and Executive Director Presentation Unknown Analyst So I'm [indiscernible]. I cover biotech space in Europe for UBS. I just would like to introduce Dr. Blanco, CEO for CTI. So you can have probably a 25 minutes presentation. James A. Bianco Than...

CLD Integrates Tin Can API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard

Custom Learning Designs, Inc.(CLD) unveils the first complete tracking to reporting eLearning solution using Tin Can API combined with its own proprietary Excelerometer report and dashboard tool. CLD is a leading developer of training content and solutions for pharmaceutical, biotech, and medical device companies worldwide. Belmont, MA (PRWEB) May 21, 2013 Custom Learning Designs, Inc.(CLD) unvei...

Amicus Therapeutics' CEO Presents at 2013 UBS Global Healthcare Conference (Transcript)

Amicus Therapeutics, Inc. (FOLD) 2013 UBS Global Healthcare Conference Call May 21, 2013 1:30 PM ET Executives John Crowley – Chairman and CEO Analysts Matthew Roden - UBS Presentation Matthew Roden - UBS Good evening everyone. My name is Matt Roden. I am one of biotech analyst here at UBS and I'd like to thank everyone for attending the new UBS Global Healthcare Conference. I a...

Audax Group Announces Acquisition of Chesapeake IRB

Audax Group announced it has completed the recapitalization of Chesapeake Research Review, Inc., d/b/a Chesapeake IRB (“Chesapeake”). Headquartered in Columbia, Maryland, Chesapeake is a leading provider of independent institutional review board (“IRB”) services to major pharmaceutical, biotech and medical device companies, universities, academic m...

Gene Patents, Angelina Jolie, and Reality

By Dr. Hans Sauer, J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization  Angelina Jolie recently announced her personal connection with breast cancer and Myriad’s BRCA genetic test.  While Jolie’s post was...

A Trio Of Strategic VCs Helps To Back Effector Therapeutics With $45 Million

Using technology spun out of UCSF, a new company hopes to develop oncology drugs that target effector mechanisms of protein synthesis, thereby affecting multiple oncogenes simultaneously. The San Diego-based biotech also hopes to license out its plat...

Achillion Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 03:30 PM

Achillion Pharmaceuticals, Inc. (ACHN) May 21, 2013 3:30 pm ET Executives Mary Kay Fenton - Chief Financial Officer, Principal Accounting Officer, Senior Vice President and Secretary Analysts Matthew Harrison - UBS Investment Bank, Research Division Presentation Matthew Harrison - UBS Investment Bank, Research Division Afternoon, everybody. I'm Matthew Harrison, one of the biotech...

Patheon Announces Changes to its Commercial Operations Structure

TORONTO, May 21, 2013 /PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, announced today that Antonella Mancuso, President, Global Commercial Operations and Chief Manufacturing Officer, notified the company that she plans to resign from her positions with the company and its subsidiari...

Karyopharm Scores $48M Series B To Advance Early Cancer Compounds

The Massachusetts biotech has remained well-funded despite shying away from venture capital investors and seeking funds from private investors.

ADC Bio Expands Lab Services in Response to Demand

ADC Biotechnology says demand for antibody drug conjugates (ADC) services has skyrocketed as it receives a second financial boost to development in four months. 

BIO Issues Call for Paper and Panel Submissions for 2013 Pacific Rim Summit on Industrial Biotech and Bioenergy

The Biotechnology Industry Organization (BIO) invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers and posters for the 2013 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 8-11, 2013 in San Diego. Participa...

Q1 Productions Hosts 2nd Annual Strengthening Patient Advocacy Relations across the Life Science Industry Conference

Life Science Professionals gather to explore patient advocacy opportunities through communication strategies used to initiate global patient group outreach, quantifying a patient advocacy program to prove value, as well as identifying a logical patient integration timeline within varying stages of product development. In Chicago this July 30-31st, Q1 P...

Sunovion Pharmaceuticals Inc. Presents Data Showing 12 Months of Latuda® (lurasidone HCl) Treatment Resulted in Higher Remission Rates in Adult Patients with Schizophrenia Compared to Seroquel XR® (quetiapine XR)

Presented at the 166th American Psychiatric Association Annual Meeting in San Francisco Sunovion Pharmaceuticals Inc. today announced results from a post-hoc study analysis showing that adult patients with schizophrenia who were treated with Latuda® (lurasidone HCl) were more likely to achieve sustained remission over 12 months of treatment compared t...

Biodesix to Announce Results of VeriStrat® Biomarker Study

Independent Phase III Data to Be Presented at the 2013 ASCO Annual Meeting Biodesix, Inc., announced that final results of the first completed biomarker-stratified, validation study in oncology will be presented at the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, May 31st – June 4th, 2013. The Randomized Pr...

Cellectis: Compact TALENTM: the next generation of TAL effector nucleases

The Scientific journal Nature Communications publishes an innovative study on ultra-precise Compact TALENTM mini DNA cutters Regulatory News: Cellectis (Paris:ALCLS) (NYSE PA: ALCLS), the global genome engineering specialist, announced today that the high-impact scientific journal Nature Communications has published an in-house study o...

Biogen Idec files BLA for MS drug Plegridy in USA

US biotech company Biogen Idec (Nasdaq: BIIB) has submitted a Biologics License Application (BLA) to the US Food and Drug Administration for approval of Plegridy (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for r...

BIO Welcomes EPA Proposed Rule on New RFS2 Pathways

The Biotechnology Industry Organization (BIO) today welcomed the opportunity for public comment on proposed Renewable Fuel Standard (RFS2) amendments and clarifications, which include new pathway determinations for advanced biofuels such as isobutanol and ethanol from crop residues. Brent Erickson, executive vice president of BIO’s Industrial &a...

Bothering To Look: With New Tools, Biotech Goes Back To The Black Box

For decades drug discovery meant testing new compounds in cells and animals without knowing how or why they might work. A shift to reductionist, target-based discovery has done little to nothing to bring more drugs to market.

ACRO Joins Coalition of Small Business Innovators

CSBI Encourages a Tax Code that Promotes Economic Growth and Creates Jobs The Association of Clinical Research Organizations announced today it has joined the Coalition of Small Business Innovators (CSBI). CSBI is a

BIO Joins Coalition of Small Business Innovators

CSBI Encourages a Tax Code that Promotes Economic Growth and Creates Jobs The Biotechnology Industry Organization (BIO) announced today it has joined the Coalition of Small Business Innovators (CSBI). CSBI is a national, non-partisan coalition of organizations dedicated to stimulating sustained, private investment in small, highly innovative com...

Transgene Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former Executives

The Start-up Company Will Develop Therapeutic Antibodies against Novel Targets in the Fields of Cancer and Inflammation Regulatory News: Transgene SA (Euronext Paris: TNG)(Paris:TNG), a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, today...

Russell Reynolds Associates Adds Sofie Qiao to San Francisco Office and Max Zuckerman to the Palo Alto Office

Search Firm Elevates Healthcare Sector and the Technology Sector Global executive search and assessment firm Russell Reynolds Associates today announced the addition to the San Francisco office of Sofie Qiao as Executive Director of the Healthcare Sector, and Max Zuckerman as Associate in the Technology Sector based in Palo Alto. Sofie Qiao jo...